RBI Assistant 2026, March 7: 650 Posts, Applications Close March 8
RBI Assistant 2026: 650 posts, applications close on March 8. See eligibility pointers, how to apply online, and why this hiring matters for India’s BFSI sector.
-
-
March 07: US 30-Day Waiver Lets India Tap Stranded Russian Oil
India Russian oil waiver: 30-day US license lets Indian refiners buy over 10 million barrels of stranded Russian crude amid Iran conflict and Hormuz Strait risk. Impact on prices, inflation, and the 1
-
March 07: AUKUS Tested as US Sub Sinks Iran Warship Near Sri Lanka
Australians aboard a US sub that sank Iran’s IRIS Dena near Sri Lanka test AUKUS and the law of naval warfare. What the israel iran conflict australia means for trade and investors.
-
INDIAVIX.NS Today, March 7: Slides nearly 15% as Sensex Rebounds
India VIX today slides nearly 15% as Sensex rebounds 900 points. What it signals for Nifty 50, options, and market volatility in India. Key drivers and next steps.
-
Nikkei 225 Futures Today, March 7: Night Session Closes -1,710 at 54,020
Nikkei 225 futures fell sharply in the night session, closing down 1,710 at 54,020. We explain what drove the move, key levels to watch in Japan stock market today, and how investors can respond amid
-
TRON USD Faces -0.11% Daily Slide as $0.27 Monthly Target Nears
TRON USD drops 0.11% today. Explore technical analysis, price forecast, and market sentiment for TRXUSD as it approaches $0.27 support.
-
PARA Stock Today: March 7 – Pluto TV Adds Fringe, FAST Deals Heat Up
Pluto TV adds all 100 episodes of Fringe as FAST deals accelerate. What this means for Paramount Global stock, ad-supported TV growth, and Canadian investors on March 7.
-
LMT Stock Today: March 7 — NORAD Tracks Russian TU‑142 Near Alaska
Lockheed Martin stock today: NORAD tracks Russian TU‑142 near Alaska. What this means for F‑35 demand, LMT price action, key levels, and the outlook for Canadian investors.
-
March 7: FDA Vaccine Chief Vinay Prasad Exit Adds Biotech Uncertainty
Vinay Prasad to leave FDA vaccine post in April, raising biotech regulatory risk and drug approvals uncertainty. What this means for US investors, timelines, and funding.
-
Solana USD Retreats 4.40% as $47.55 Monthly Target Emerges
Solana USD drops 4.40% today. Technical analysis shows RSI at 42.44 and strong ADX trend. Monthly forecast targets $47.55 amid market volatility.
